<?xml version="1.0" encoding="UTF-8"?>
<p id="par0075">In the previous SARS and MERS-CoV epidemics, acute kidney injury (AKI) developed in 5–15% of cases and had a high mortality rate (60–90%) 
 <xref rid="bib0170" ref-type="bibr">[34]</xref>, 
 <xref rid="bib0190" ref-type="bibr">[38]</xref>, 
 <xref rid="bib0195" ref-type="bibr">[39]</xref>. Kidney injury was also associated with an increased risk of death in patients with influenza A virus subtype H1N1 
 <xref rid="bib0200" ref-type="bibr">[40]</xref>. Similar results have been found for the current SAS-CoV-2 pandemic. In a postpartum study of patients from Wuhan from January to the beginning of March, Diao et al 
 <xref rid="bib0045" ref-type="bibr">[9]</xref> showed that 27.06% (23/85) patients exhibited acute renal failure. However, another study conducted in a similar time frame in a hospital in Wuhan did not have anyone to develop or die of acute renal failure 
 <xref rid="bib0165" ref-type="bibr">[33]</xref>. Several studies in China have tracked the development of AKI once admitted for COVID-19. A smaller study of 41 patients found that thee (7%) developed AKI. Other studies in Wuhan have found rates around 3–4% in a similar time frame 
 <xref rid="bib0030" ref-type="bibr">[6]</xref>, 
 <xref rid="bib0125" ref-type="bibr">[25]</xref>. One study of 1099 cases from mainland China showed that six (0.5%) COVID-19 patients developed AKI 
 <xref rid="bib0025" ref-type="bibr">[5]</xref>.
</p>
